Dr. Merchant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd., A9102
Los Angeles, CA 90048Phone+1 310-423-1160
Summary
- Dr. Akil Merchant is co-Director of the Lymphoma Program at Cedars-Sinai Medical Center in Los Angeles, CA. He did his fellowship in Medical Oncology at Johns Hopkins University and was on the faculty at LAC-USC and the USC Norris Cancer center. He specializes lymphoma treatment and cellular therapies including CART and bone marrow transplantation.
Clinical Expertise
- Bone marrow transplantation, Leukemia, Hematologic oncology, Myeloproliferative disease, Oropharyngeal lymphoma
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
Baylor College of MedicineResidency, Internal Medicine, 2000 - 2005- Baylor College of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2012 - 2025
MD State Medical License 2005 - 2013
TX State Medical License 2002 - 2005- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Start of enrollment: 2013 Dec 24
- Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA Start of enrollment: 2013 Dec 01
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia Start of enrollment: 2018 May 09
- Join now to see all
Publications & Presentations
PubMed
- High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.Waseem Lone, Alyssa Bouska, Tyler A Herek, Catalina Amador, Joo Song
American Journal of Hematology. 2025-01-01 - Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.Medha Somisetty, Philip C Mack, Chih-Yuan Hsu, Yuanhui Huang, Jorge E Gomez
Clinical Lung Cancer. 2024-11-01 - Low booster uptake in cancer patients despite health benefits.Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin
Iscience. 2024-09-20
Abstracts/Posters
- Highly Multiplexed Single Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Predicts Clinical OutcomesAkil Merchant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin LymphomaAkil Merchant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Researchers Identify Patterns That Predict Ovarian Cancer RelapseApril 18th, 2024- A Leading-Edge Lymphoma ProgramDecember 21st, 2022
- The More Pandemic Precautions Fall Away, the More COVID Risk Is Concentrated on This One GroupDecember 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
